Cisplatin Intravenous and Hemolytic anemia
Result of checking the interaction of drug Cisplatin Intravenous and disease Hemolytic anemia for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:A (+) Coombs' hemolytic anemia has been reported with the use of cisplatin. Subsequent therapy may result in increased hemolysis. If need outweighs the risk, extreme caution should be exercised in administering cisplatin. Patients should be instructed to immediately report signs and symptoms suggesting anemia such as fatigue, weakness, and/or bloody urine. Therapy with cisplatin should be administered cautiously in patients with anemia and those with a history of or a predisposition to hemolytic syndromes. Close clinical monitoring of hematopoietic function for hemolysis and anemia is recommended.
- "Product Information. Platinol (cisplatin)." Bristol-Myers Squibb, Princeton, NJ.
Generic Name: cisplatin
Brand Name: Platinol, Platinol-AQ
Synonyms: Cisplatin, CISplatin